Perseo Pharma

We are breaking new ground in the treatment of metabolic diseases Media Release September 18, 2026 Our Digeia® drug platform has successfully completed a GLP toxicology study, demonstrating an excellent safety profile with no treatment-related adverse findings and a NOAEL established at the highest…

Health and bio Media and content

Latest funding

Series A · January 19, 2026

Amount not disclosed in a source on record.

Funding history ↓

Website: perseo-pharma.com.

Categories: Health and bio Media and content.

Stage: Series A.

Last round: Jan 19, 2026 · 297 days ago.

On Recent Funding since: Nov 6, 2026.

Signals

Website registeredNov 1, 2018 (8 years old)

Funding rounds

January 19, 2026
Series A · amount undisclosed
Source: fundraisingfox.com
November 1, 2018
Website created

Companies like Perseo Pharma

HHotSpot Therapeutics$100M Series B+ · Nov 2021
AActio Biosciences$66M Series B+ · Jun 2025
AAltruBio$225M Series B+ · May 2024
SSable Bio
BBiossil$153M Seed · Sep 2026
MMandolin$40M Series A · Jun 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/perseo-pharma (get a free API key).